INIFY LABORATORIES AB Cash Flow-to-Debt Ratio

Latest as of December 2025: -1.26x

INIFY LABORATORIES AB cash flow-to-debt ratio. INIFY LABORATORIES AB (WY60) has a Cash Flow-to-Debt Ratio of -1.26x as of December 2025, meaning its operating cash flow of €-42.86 Million could theoretically repay -1% of its total liabilities (€34.02 Million) in one year. See WY60 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-1.26x
Operating CF / Total Liabilities

Operating Cash Flow

€-42.86 Million
EUR

Total Liabilities

€34.02 Million
EUR

Data as of

Dec 2025
Most recent filing

Cash Flow-to-Debt Ratio of INIFY LABORATORIES AB (2024–2025)

Cash flow-to-debt ratio of INIFY LABORATORIES AB from 2024 to 2025. Historical debt coverage capacity for INIFY LABORATORIES AB across 2 annual periods. Also explore WY60 shareholders equity momentum to track the company's year-over-year net asset growth rate.

INIFY LABORATORIES AB Cash Flow-to-Debt Ratio by Year (2024–2025)

INIFY LABORATORIES AB cash flow-to-debt ratio by year from 2024 to 2025. Year-by-year debt coverage analysis for INIFY LABORATORIES AB. For the full cash flow conversion analysis, see cash flow conversion of INIFY LABORATORIES AB.

Year CF-to-Debt Ratio Operating CF (EUR) Total Liabilities YoY Change
2025 -1.26x €-42.86 Million €34.02 Million ▲ +74.3%
2024 -4.90x €-46.57 Million €9.50 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.